Products Categories
CAS No.: | 13171-25-0 |
---|---|
Name: | Trimetazidine dihydrochloride |
Article Data: | 2 |
Molecular Structure: | |
Formula: | C14H24Cl2N2O3 |
Molecular Weight: | 339.262 |
Synonyms: | Piperazine, 1-(2,3,4-trimethoxybenzyl)-, dihydrochloride;Kyurinett;Piperazine, 1-((2,3,4-trimethoxyphenyl)methyl)-, dihydrochloride (9CI);1-[(2,3,4-trimethoxyphenyl)methyl]-2,3,5,6-tetrahydropyrazine;1-[(2,3,4-trimethoxyphenyl)methyl]piperazine dihydrochloride;Trimetajust;Lubomail;Piperazine,1-[(2,3,4-trimethoxyphenyl)methyl]-,dihydrochloride;Prestwick_871;S 4004; |
EINECS: | 236-117-0 |
Melting Point: | 231-235 °C |
Boiling Point: | 364 °C at 760 mmHg |
Flash Point: | 174 °C |
Appearance: | crystalline solid |
Hazard Symbols: | Xi,Xn |
Risk Codes: | 22-36/37/38 |
Safety: | 26-36 |
PSA: | 42.96000 |
LogP: | 2.98830 |
What can I do for you?
Get Best Price
The IUPAC name of Yosimilon is 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine dihydrochloride. With the CAS registry number 13171-25-0, it is also named as Trimetazidine dihydrochloride. The product's categories are Intermediates & Fine Chemicals; Pharmaceuticals. Besides, it is crystalline solid, which should be stored in an airtight, cool, dry and ventilated place. It is a vasodilator used in angina of effort or ischemic heart disease. In addition, its molecular formula is C14H24Cl2N2O3 and its molecular weight is339.258.
The other characteristics of Yosimilon can be summarized as: (1)EINECS: 236-117-0; (2)ACD/LogP: 0.80; (3)# of Rule of 5 Violations: 0; (4)ACD/LogD (pH 5.5): -2.16; (5)ACD/LogD (pH 7.4): -0.82; (6)ACD/BCF (pH 5.5): 1; (7)ACD/BCF (pH 7.4): 1; (8)ACD/KOC (pH 5.5): 1; (9)ACD/KOC (pH 7.4): 1.57; (10)#H bond acceptors: 5; (11)#H bond donors: 1; (12)#Freely Rotating Bonds: 5; (13)Polar Surface Area: 34.17 Å2; (14)Flash Point: 174 °C; (15)Melting Point: 231-235 °C; (16)Enthalpy of Vaporization: 61.02 kJ/mol; (17)Boiling Point: 364 °C at 760 mmHg; (18)Vapour Pressure: 1.73E-05 mmHg at 25 °C.
When you are using this chemical, please be cautious about it as the following: it is irritating to eyes, respiratory system and skin. It is also harmful if swallowed. You should wear suitable protective clothing. Moreover, in case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
People can use the following data to convert to the molecule structure.
(1)SMILES: Cl.Cl.O(c1ccc(c(OC)c1OC)CN2CCNCC2)C
(2)InChI: InChI=1/C14H22N2O3.2ClH/c1-17-12-5-4-11(13(18-2)14(12)19-3)10-16-8-6-15-7-9-16;;/h4-5,15H,6-10H2,1-3H3;2*1H
(3)InChIKey: VYFLPFGUVGMBEP-UHFFFAOYAP
(4)Std. InChI: InChI=1S/C14H22N2O3.2ClH/c1-17-12-5-4-11(13(18-2)14(12)19-3)10-16-8-6-15-7-9-16;;/h4-5,15H,6-10H2,1-3H3;2*1H
(5)Std. InChIKey: VYFLPFGUVGMBEP-UHFFFAOYSA-N
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 305mg/kg (305mg/kg) | United States Patent Document. Vol. #3262852, | |
mouse | LD50 | intravenous | 125mg/kg (125mg/kg) | United States Patent Document. Vol. #3262852, | |
mouse | LD50 | oral | 1550mg/kg (1550mg/kg) | Drugs in Japan Vol. 6, Pg. 527, 1982. | |
mouse | LD50 | subcutaneous | 410mg/kg (410mg/kg) | Drugs in Japan Vol. 6, Pg. 527, 1982. | |
rat | LD50 | intraperitoneal | 345mg/kg (345mg/kg) | Drugs in Japan Vol. 6, Pg. 527, 1982. | |
rat | LD50 | oral | 1700mg/kg (1700mg/kg) | Drugs in Japan Vol. 6, Pg. 527, 1982. | |
rat | LD50 | subcutaneous | 1500mg/kg (1500mg/kg) | Drugs in Japan Vol. 6, Pg. 527, 1982. |